Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYN-010 Extension Study in IBS-C
NCT02493036Phase 2Completed
- Sponsor
- Theriva Biologics
- Start
- Oct 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYN-010 in irritable bowel syndrome (IBS), sponsored by Theriva Biologics. Started Oct 2015; status: completed.
02
Drugs
SYN-010
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02493036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493036.